Lv32
360 积分 2022-11-11 加入
A patent review of DNA polymerase theta (Polθ) targeted therapies (2019–2025)
19小时前
待确认
Allosteric CDC37 Inhibitor Disrupts Chaperone Complex to Block CDK4/6 Maturation
15天前
已完结
Targeting EGFR degradation by autophagosome degraders
2个月前
已完结
Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
2个月前
已完结
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery
2个月前
已完结
Recent update on the development of EZH2 inhibitors and degraders for cancer therapy
2个月前
已完结
Abstract 3307: c-Met targeting chaperone-mediated protein degrader for therapeutic intervention in NSCLC
2个月前
已关闭
c-Met targeting chaperone-mediated protein degrader for therapeutic intervention in NSCLC
2个月前
已关闭
Aurora A degradation by HSP90 interactome-mediating PROTACs in A549 and paclitaxel-resistant A549 cells
3个月前
已完结
An updated patent review of BRD4 degraders
3个月前
已完结
皖公网安备34019202002308
